These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. [Role of pharmacologic or exercise stress echocardiography for the assessment of hemodynamics in valvular heart disease]. Sicari R; La Falce S G Ital Cardiol (Rome); 2011 Oct; 12(10):645-51. PubMed ID: 21947107 [TBL] [Abstract][Full Text] [Related]
16. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease. Cheitlin MD; Douglas PS; Parmley WW J Am Coll Cardiol; 1994 Oct; 24(4):874-80. PubMed ID: 7930219 [No Abstract] [Full Text] [Related]
17. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease. Cheitlin MD; Douglas PS; Parmley WW Med Sci Sports Exerc; 1994 Oct; 26(10 Suppl):S254-60. PubMed ID: 7934748 [No Abstract] [Full Text] [Related]